Nectar Social | $10,600,000 | (Jun 6, 2025)
Voltrac | $2,286,772 | (Jun 6, 2025)
Signify Bio | $15,000,000 | (Jun 6, 2025) Certified by Founder
Lodge
C the Signs
start up
United Kingdom
- London
- 31/01/2025
- Unknown
- $8,000,000
C the Signs is a cancer prediction system that can identify patients at risk of cancer at the earliest and most curable stage of the disease.
In under 30 seconds, C the Signs can rapidly identify which cancers a patient is at risk of and recommend the most appropriate test or specialist to diagnose their cancer.
Using the latest technology, research and evidence, C the Signs enables healthcare providers to give their patients the best chance of surviving cancer.
- Industry Hospital & Health Care
- Website https://www.cthesigns.com/
- LinkedIn https://www.linkedin.com/company/c-the-signs/
Allay Therapeutics | $57,500,000 | (Jun 6, 2025)
Flank | $10,000,000 | (Jun 6, 2025)
Obvio | $22,000,000 | (Jun 5, 2025)
Manex AI | $9,142,230 | (Jun 5, 2025)
Filament Syfter | $4,800,000 | (Jun 5, 2025)
Vivrelle | $62,000,000 | (Jun 5, 2025)
Sema4.ai | $25,000,000 | (Jun 5, 2025)
Aive | $13,700,350 | (Jun 5, 2025)
Delpha | $2,000,000 | (Jun 5, 2025)